Synergistic activity of dobutamine combined with azoles and its mechanism of action against strains of Candida glabrata

Future Microbiol. 2022 Apr:17:437-448. doi: 10.2217/fmb-2020-0256. Epub 2022 Mar 14.

Abstract

Aims: To evaluate the antifungal effect of dobutamine against Candida glabrata as well as its synergism with azoles and its action on biofilm. Methods: The M27-A3 protocol and flow cytometry were used for elucidation of the possible mechanism of action. Results: The tested isolates presented MICs ranging from 2 to 32 μg/ml for dobutamine, with fungistatic effect. A total of 82% of the strains showed synergism with fluconazole, with 90% showing synergism with itraconazole. The effect on biofilm formation was nonsignificant. Cytometry tests showed that dobutamine induced mitochondrial depolarization. Conclusion: Dobutamine has an antifungal effect on strains of C. glabrata and synergistic activity with azoles. This effect is probably mediated by increased oxidative damage to the membrane.

Keywords: Candida glabrata; EROs; redirection; resistance; synergism.

MeSH terms

  • Antifungal Agents / pharmacology
  • Azoles* / pharmacology
  • Candida glabrata*
  • Dobutamine / pharmacology
  • Drug Resistance, Fungal
  • Fluconazole / pharmacology
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Azoles
  • Dobutamine
  • Fluconazole